Concord Drugs Ltd.
BSE: 538965 | Sector: Health care |
NSE: N.A. | ISIN Code: INE858L01010 |
BSE 00:00 | 24 Jun | 21.25 |
-3.10 (-12.73%) |
OPEN
26.40 |
HIGH
26.40 |
LOW
19.50 |
NSE 05:30 | 01 Jan | Concord Drugs Ltd |
OPEN | 26.40 |
PREVIOUS CLOSE | 24.35 |
VOLUME | 5280 |
52-Week high | 37.40 |
52-Week low | 19.50 |
P/E | 11.68 |
Mkt Cap.(Rs cr) | 19 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Concord Drugs Ltd.
CONCORD DRUGS LIMITED is a public limited company established in 1995 is among the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small volume parenterals Dry powder ) Tissue Bio-Adhesive tablets capsules and ophthalmic preparations and Ready-to-fill Pellets.State of the art technology having dedicated manufacturing facilitie...> More
Concord Drugs Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
19 | |
EPS - TTM | (![]() |
[*S] | 1.82 |
P/E Ratio | (X) | [*S] | 11.68 |
Face Value | (![]() |
10 | |
Latest Dividend | (%) | - | |
Latest Dividend Date | - | ||
Dividend Yield | (%) | 0.00 | |
Book Value / Share | (![]() |
[*S] | 32.44 |
P/B Ratio | (![]() |
[*S] | 0.66 |
Announcement
-
Announcement under Regulation 30 (LODR)-Resignation of Director
-
Audited Financial Results For Quarter And Financial Year Ended 31St March 2022.
-
Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended 31.03.2022
-
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Concord Drugs Ltd - Financial Results
Particulars (![]() |
Mar 2022 | Mar 2021 | % Chg |
Net Sales | 15.46 | 8.35 | 85.15 |
Other Income | 0.02 | 0.26 | -92.31 |
Total Income | 15.49 | 8.61 | 79.91 |
Total Expenses | 14.81 | 7.62 | 94.36 |
Operating Profit | 0.68 | 0.99 | -31.31 |
Net Profit | 0.03 | 0.34 | -91.18 |
Equity Capital | 8.74 | 8.74 | - |
Concord Drugs Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Transchem | 19.60 | 1.03 | 23.99 |
Roopa Industries | 27.50 | 0.73 | 21.64 |
Panjon | 13.25 | -2.21 | 20.54 |
Concord Drugs | 21.25 | -12.73 | 18.57 |
Ortin Labs. | 21.30 | 2.90 | 17.32 |
Phaarmasia | 23.30 | 0.00 | 15.91 |
Shukra Pharma. | 99.55 | 4.40 | 15.63 |
Concord Drugs Ltd - SHAREHOLDING PATTERN
|
|
Concord Drugs Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | -15.00% | NA | 2.66% | 2.65% |
1 Month | -21.88% | NA | -2.45% | -2.64% |
3 Month | -29.17% | NA | -8.45% | -8.85% |
6 Month | -30.44% | NA | -7.70% | -7.67% |
1 Year | -36.38% | NA | 0.05% | -0.58% |
3 Year | -2.75% | NA | 34.78% | 34.19% |
Concord Drugs Ltd - STOCK STRENGTH
Today's Low/High | 19.50 | 26.40 | |
Week Low/High | 19.50 | 27.00 | |
Month Low/High | 19.50 | 30.00 | |
YEAR Low/High | 19.50 | 37.00 | |
All TIME Low/High | 11.68 | 91.00 |
Quick Links for Concord Drugs:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices